Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
about
Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytesVogt-Koyanagi-Harada syndrome - current perspectives.Upcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system.Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant.Intravitreal triamcinolone acetonide for rebound phenomenon after high-dose intravenous steroid treatment in Vogt-Koyanagi-Harada diseaseRituximab in refractory Vogt-Koyanagi-Harada disease.The use of intraocular corticosteroids.Intraocular corticosteroids for posterior segment disease: 2012 update.Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt-Koyanagi-Harada disease.Clinical spectrum and management options in Vogt-Koyanagi-Harada disease.The problem of pressure elevation associated with intravitreal triamcinolone.Intravitreal triamcinolone for intraocular inflammation and associated macular edema.Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease.Pharmacotherapeutic efficacy of preservative-free intravitreal triamcinolone acetonide.Low-dose intraocular triamcinolone injection for intractable macular oedema and inflammation in patients with uveitis.Adalimumab Treatment in Patients with Vogt-Koyanagi-Harada Disease.Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis
P2860
Q26752297-C5BE1C72-E2FD-4AC8-BA75-E0453F387C71Q28072882-ED0ACF2B-8797-4BE2-B444-D8D99BE19918Q33790255-047DADAF-01DA-4080-B128-76998A6BD871Q34399826-5AC710F5-6C0B-4149-BBB4-CD69EE850D3CQ35555776-1331FBB8-EB7D-40CF-AD0B-375FDE596D69Q35571023-019DFE4B-4033-44FD-A354-DB7D3B70BE16Q37598893-1B2F6263-926C-4BB0-BEE8-D60D82B87E05Q38025444-A9D51FCE-9DEC-4E64-8C40-0152454A5D06Q41189743-8F04538A-220D-46EF-808E-9EEFEB259547Q41405377-2D86C50D-3968-4654-8A61-E9C16C06A9ADQ42841761-043A7F92-3500-4104-8B61-47717888C2FBQ43096392-17DD9D8B-433D-4ED4-8B83-77EC072A207DQ43187434-08335829-F262-4C0B-A60D-E83F12E77787Q43225793-27C270A7-5AB8-406A-A3AE-799BC37A3E80Q46647067-BF6969AB-C238-4D2C-9A90-A2658C0E09FCQ47654494-91199168-19F9-4E56-84E4-A79209F7B08BQ50544506-A57EC1D3-BBC5-424F-8198-35B63F12BDE9Q58326103-11213E1B-E6B9-404C-AC0E-9AF73713C5E2
P2860
Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Intravitreal triamcinolone in ...... Vogt-Koyanagi-Harada syndrome.
@en
type
label
Intravitreal triamcinolone in ...... Vogt-Koyanagi-Harada syndrome.
@en
prefLabel
Intravitreal triamcinolone in ...... Vogt-Koyanagi-Harada syndrome.
@en
P2093
P1476
Intravitreal triamcinolone in ...... Vogt-Koyanagi-Harada syndrome
@en
P2093
Cristina Muccioli
Michel E Farah
Rafael E Andrade
P304
P356
10.1016/J.AJO.2003.08.035
P407
P577
2004-03-01T00:00:00Z